Topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis: an open-label pilot study.

Purpose: To evaluate the feasibility of tacrolimus 0.03% dermatological ointment (Protopic) in the treatment of intractable allergic conjunctivitis.

Methods: Twenty patients (mean age 10.